A team of researchers at the University of Oxford’s Department of Psychiatry, supported by the NIHR Biomedical Research Centre (BRC): Oxford Health, has discovered Alzheimer’s disease-related proteins in cervical lymph…
In a recent randomised clinical trial it was found that cognitive behavioural therapy for insomnia (CBT-I) did not significantly alter emotional processing of facial expressions following treatment in individuals with clinically…
Professor Cathy Creswell, BRC: Oxford Health Mental Health in Development Theme Lead, has contributed to a new report into children and young people’s mental health, published as part of the…
A paper published today in Nature Mental Health reports on how GLP-1RAs, drugs approved for diabetes and obesity, might be useful for the treatment of cognitive and mental health disorders….
Researchers in the BRC: Oxford Health’s Mental Health in Development Theme have launched the Parent Carer Research Network, which champions the voices of parents and carers in research. The network…
Researchers in the Mental Health Mission’s Early Psychosis workstream have developed a psychosis risk prediction tool which aims to help GPs detect the early signs of psychosis, potentially reducing the…
Researchers from Oxford Health Biomedical Research Centre have led on a study into the real-world effects of antidepressants in adults in England. Over 673,000 people diagnosed with depressive disorders took…
Oxford and Southampton researchers have found that atomoxetine and a class of drug known as stimulants are the most effective treatments in the management of attention deficit hyperactivity disorder (ADHD)…
New research, funded by our Oxford Health Biomedical Research Centre, has found that poor cardiovascular health in childhood, adolescence and young adulthood may contribute to brain structure changes linked to…
Colleagues from our BRC’s Mental Health in Development theme have established a network to facilitate relationships between schools and mental health researchers. The WISDOM Research Network brings together primary and…
The NIHR Mental Health Translational Research Collaboration (MH-TRC) secured over £42m of funding to establish the Mental Health Mission (MHM) in 2023. The MHM, in collaboration with the ASCEnD trial…
GPs will be able to support patients with difficult to treat depression through 7 new specialist clinics across the UK, widening access to clinical assessments and new treatments. The NIHR…
New research, supported by our BRC Molecular Targets’ Theme Co-Leads Professors Paul Harrison and Rachel Upthegrove and BRC Dementia Theme Co-Lead Professor Masud Husain, has found that patients who were…
Leading scientists say that while poor air quality is a risk factor for mental illness, progress in understanding the causes and impact has been too slow. In a paper published…
Triptans, a drug usually offered as an alternative to painkillers, have been found to be the most effective medicine for adults who experience acute migraines. Findings of a study, which…
Researchers from our BRC Data Science Theme have contributed to an article on the use of Electronic Health Records (EHRs) to facilitate personalised treatments for psychiatric conditions. Clinical prediction models…
This week, a product licence for the medicine lecanemab (Leqembi) was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to treat adult patients in the early stages of…
Research supported by University of Oxford’s Department of Experimental Psychology Prof. Anke Ehlers, Theme Lead of the BRC’s Psychological Treatments Theme, has found that the type of coping strategy used…
A prescription treatment for insomnia developed by Big Health has received US Food and Drug Administration (FDA) approval this week. Big Health joint co-founder University of Oxford’s Prof Colin Espie…
Increasing serotonin can change how people learn from negative information, as well as improving how they respond to it, according to a new study published in the leading journal Nature…
